Stephen Daniels

University of Colorado Hospital — United States

Medicine · Health Sciences

18h-index1.2kcitations27works1.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory mediators and NSAID effects(16), Anesthesia and Pain Management(13), Pain Management and Opioid Use(9), Pain Mechanisms and Treatments(4), Analytical Methods in Pharmaceuticals(4)

Publications27 total

Instability and the Anatomic Total Shoulder Arthroplasty
Journal of the American Academy of Orthopaedic Surgeons·2024· 1 cited
Celecoxib‐tramadol co‐crystal in patients with moderate‐to‐severe pain following bunionectomy with osteotomy: Secondary analyses by baseline pain intensity and use of rescue medication of a phase 3, randomized, double‐blind, factorial, active‐ and placebo‐controlled trial
Pain Practice·2024· 2 citedOpen Access
Celecoxib‐tramadol co‐crystal in patients with moderate‐to‐severe pain following bunionectomy with osteotomy: A phase 3, randomized, double‐blind, factorial, active‐ and placebo‐controlled trial
Pain Practice·2022· 20 citedOpen Access
Analgesic Efficacy of a New Immediate‐Release/Extended‐Release Formulation of Ibuprofen: Results From Single‐ and Multiple‐Dose Postsurgical Dental Pain Studies
Clinical Pharmacology in Drug Development·2016· 20 citedOpen Access
Erratum to (440) Opioid-Induced Nausea and Vomiting (OINV) in Post-Operative Patients: A Comparison of CL-108 to Hydrocodone 7.5 mg/Acetaminophen 325 mg
Journal of Pain·2016Open Access
Erratum to (438) Efficacy of CL-108 Compared to Hydrocodone 7.5 mg/Acetaminophen 325 mg in Preventing Vomiting and the Use of Anti-Emetics, Opioid-Induced Nausea and Vomiting (OINV)
Journal of Pain·2016Open Access
WITHDRAWN: (440) Opioid-Induced Nausea and Vomiting (OINV) in Post-Operative Patients: A Comparison of CL-108 to Hydrocodone 7.5 mg/Acetaminophen 325 mg
Journal of Pain·2016Open Access
A randomized, phase 2 study investigating TRV130, a biased ligand of the μ-opioid receptor, for the intravenous treatment of acute pain
Pain·2015· 200 cited
Low-dose SoluMatrix diclofenac: a review of safety across two Phase III studies in patients with acute and osteoarthritis pain
Expert Opinion on Drug Safety·2015· 4 cited
200mg and 400mg of ibuprofen provide significantly longer pain relief than 500mg and 1000mg of paracetamol in dental pain
Faculty of 1000 Research Ltd·2015Open Access
Indomethacin Submicron Particle Capsules Provide Effective Pain Relief in Patients with Acute Pain: A Phase 3 Study
The Physician and Sportsmedicine·2013· 15 cited
A Phase 2 Study of Naproxen Submicron Particle Capsules in Patients with Post-Surgical Dental Pain
Advances in Therapy·2013· 7 cited
Lower-Dose Diclofenac Submicron Particle Capsules Provide Early and Sustained Acute Patient Pain Relief in a Phase 3 Study
Postgraduate Medicine·2013· 21 cited
Impact of Local Administration of Liposome Bupivacaine for Postsurgical Analgesia on Wound Healing: A Review of Data From Ten Prospective, Controlled Clinical Studies
Clinical Therapeutics·2013· 89 cited
Analgesic Efficacy and Safety of a Novel Injectable Formulation of Diclofenac Compared With Intravenous Ketorolac and Placebo After Orthopedic Surgery
Clinical Journal of Pain·2013· 25 cited
A Phase 2 Study Evaluating the Efficacy and Safety of a Novel, Proprietary, Nano-Formulated, Lower Dose Oral Diclofenac
Pain Medicine·2012· 27 citedOpen Access
A Phase I Study Evaluating the Pharmacokinetic Profile of a Novel, Proprietary, Nano-formulated, Lower-Dose Oral Indomethacin
Postgraduate Medicine·2012· 22 cited
The Pharmacokinetic Parameters of a Single Dose of a Novel Nano–formulated, Lower-Dose Oral Diclofenac
Postgraduate Medicine·2012· 29 cited
A Double-Blind Placebo-Controlled Comparison of a Novel Formulation of Intravenous Diclofenac and Ketorolac for Postoperative Third Molar Extraction Pain
Anesthesia Progress·2011· 32 citedOpen Access
Celecoxib in the treatment of primary dysmenorrhea: Results from two randomized, double-blind, active- and placebo-controlled, crossover studies
Clinical Therapeutics·2009· 39 cited
page 1 of 2Next →

Frequent Co-authors

Allan Gibofsky(4), Roy D. Altman(4), Clarence L. Young(4), Paul J. Desjardins(3), Eugene R. Viscusi(3), Michael E. Kuss(3), Garen Manvelian(3), Bernard Schachtel(3), E. Schachtel(3), Mark Marino(3), Stephen K. Richardson(3), Kyle Patrick(3), Steven Royall(3), Kerstin Malmström(2), Paul Kotey(2), Jens‐Ulrich Stegmann(2), Akiko Okamoto(2), David Upmalis(2), Douglas A. Hamilton(2), Daniel B. Carr(2)